Hims & Hers Health (HIMS) Change in Account Payables (2019 - 2026)
Hims & Hers Health's (HIMS) quarterly Change in Account Payables came in at $167.6 million in Q1 2026, up 1058.32% year-on-year from $14.5 million in Q1 2025, and up 466.02% quarter-over-quarter from -$45.8 million in Q4 2025.
Hims & Hers Health (HIMS) Change in Account Payables (2019 - 2026) Analysis & Trends
Hims & Hers Health has disclosed Change in Account Payables across 8 years of filings, most recently posting $167.6 million for Q1 2026.
- Change in Account Payables for Q1 2026 came in at $167.6 million, up 1058.32% year-over-year; the trailing twelve-month figure through Mar 2026 was $183.5 million (up 236.14% YoY), and the FY2025 annual result was $30.3 million, down 30.69% from the prior year.
- Change in Account Payables came in at $167.6 million for Q1 2026 at Hims & Hers Health, up from -$45.8 million in the prior quarter.
- In the past five years, Change in Account Payables ranged from a high of $167.6 million in Q1 2026 to a low of -$45.8 million in Q4 2025.
- The 5-year median for Change in Account Payables is $4.0 million (2023), against an average of $15.4 million.
- Across the five-year window, Change in Account Payables jumped 1922.18% in 2024 and sank 629.0% in 2025, its largest moves.
- Hims & Hers Health's Change in Account Payables stood at -$609000.0 in 2022, then surged by 579.97% to $2.9 million in 2023, then jumped by 196.2% to $8.7 million in 2024, then tumbled by 629.0% to -$45.8 million in 2025, then soared by 466.02% to $167.6 million in 2026.
- The last three Change in Account Payables figures came in at $167.6 million (Q1 2026), -$45.8 million (Q4 2025), and $71.0 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Account Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 39.72 Bn | 35.98 Bn | 1.97 Bn | - |
| 2 | Zoetis | 34.61 Bn | 32.67 Bn | 1.62 Bn | 62.00 Mn |
| 3 | United Therapeutics | 24.07 Bn | 21.91 Bn | 648.10 Mn | - |
| 4 | Aurora Cannabis | 16.98 Bn | 16.91 Bn | 33.43 Mn | - |
| 5 | Neurocrine Biosciences | 16.64 Bn | 15.32 Bn | 800.70 Mn | - |
| 6 | Elanco Animal Health | 12.19 Bn | 11.76 Bn | 785.00 Mn | - |
| 7 | Alkermes | 7.37 Bn | 6.86 Bn | -116.06 Mn | - |
| 8 | Hims & Hers Health | 6.62 Bn | 5.87 Bn | 396.79 Mn | 167.64 Mn |
| 9 | Lantheus Holdings | 6.47 Bn | 5.97 Bn | 230.92 Mn | 190,000.00 |
| 10 | Liquidia | 5.64 Bn | 5.42 Bn | 121.79 Mn | 562,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 167.64 Mn |
| Mar 31, 2026 | 167.64 Mn |
| Dec 31, 2025 | -45.80 Mn |
| Dec 31, 2025 | -45.80 Mn |
| Sep 30, 2025 | 70.95 Mn |
| Sep 30, 2025 | 70.95 Mn |
| Jun 30, 2025 | -9.33 Mn |
| Jun 30, 2025 | -9.33 Mn |
| Mar 31, 2025 | 14.47 Mn |
| Mar 31, 2025 | 14.47 Mn |
| Dec 31, 2024 | 8.66 Mn |
| Dec 31, 2024 | 8.66 Mn |
| Sep 30, 2024 | 18.90 Mn |
| Sep 30, 2024 | 18.90 Mn |
| Jun 30, 2024 | 12.55 Mn |
| Jun 30, 2024 | 12.55 Mn |
| Mar 31, 2024 | 3.60 Mn |
| Mar 31, 2024 | 3.60 Mn |
| Dec 31, 2023 | 2.92 Mn |
| Dec 31, 2023 | 2.92 Mn |